Ellen Rosenberg - Nov 24, 2025 Form 4 Insider Report for AMICUS THERAPEUTICS, INC. (FOLD)

Role
Chief Legal Officer
Signature
/s/ Christian Formica, Attorney-in-Fact
Stock symbol
FOLD
Transactions as of
Nov 24, 2025
Transactions value $
-$443,692
Form type
4
Date filed
11/26/2025, 09:16 PM
Previous filing
Feb 13, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Rosenberg Ellen Chief Legal Officer 47 HULFISH STREET, PRINCETON /s/ Christian Formica, Attorney-in-Fact 2025-11-26 0001666380

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FOLD Common Stock Options Exercise $153K +25K +4.92% $6.10 533K Nov 24, 2025 Direct
transaction FOLD Common Stock Options Exercise $56.4K +11K +2.06% $5.13 544K Nov 24, 2025 Direct
transaction FOLD Common Stock Sale -$362K -36K -6.62% $10.06 508K Nov 24, 2025 Direct F1
transaction FOLD Common Stock Options Exercise $185K +36K +7.09% $5.13 544K Nov 25, 2025 Direct
transaction FOLD Common Stock Sale -$360K -36K -6.62% $10.00 508K Nov 25, 2025 Direct
transaction FOLD Common Stock Options Exercise $121K +23.6K +4.65% $5.13 531K Nov 26, 2025 Direct
transaction FOLD Common Stock Sale -$236K -23.6K -4.45% $10.00 508K Nov 26, 2025 Direct
holding FOLD Common Stock 15K Nov 24, 2025 By Spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FOLD Stock Options (right to buy) Options Exercise $0 -25K -100% $0.00 0 Nov 24, 2025 Common Stock 25K $6.10 Direct F2
transaction FOLD Stock Options (right to buy) Options Exercise $0 -11K -15.58% $0.00 59.6K Nov 24, 2025 Common Stock 11K $5.13 Direct F2
transaction FOLD Stock Options (right to buy) Options Exercise $0 -36K -60.38% $0.00 23.6K Nov 25, 2025 Common Stock 36K $5.13 Direct F2
transaction FOLD Stock Options (right to buy) Options Exercise $0 -23.6K -100% $0.00 0 Nov 26, 2025 Common Stock 23.6K $5.13 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $10.00 to $10.31 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2 All of the options were fully vested and exercisable as of the transaction date.

Remarks:

All transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 10, 2024.